This topic contains a solution. Click here to go to the answer

Author Question: The nurse has provided patient teaching about potassium sparing diuretic therapy. Which statement by ... (Read 47 times)

KimWrice

  • Hero Member
  • *****
  • Posts: 579
The nurse has provided patient teaching about potassium sparing diuretic therapy. Which statement by the patient indicates a need for further teaching?
 
  a. I will take my medication in the morning.
  b. I will report a weight gain of 2 pounds in 2 days.
  c. I will rise slowly when I get up from a sitting position.
  d. I will use a salt substitute because I limit my salt intake.

Question 2

Which medication, if administered with spironolactone (Aldactone), will alert the nurse to assess the patient for signs and symptoms of hyperkalemia?
 
  a. Propranolol (Inderal)
  b. Captopril (Capoten)
  c. Furosemide (Lasix)
  d. Ibuprofen (Motrin)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

okolip

  • Sr. Member
  • ****
  • Posts: 362
Answer to Question 1

ANS: D
Salt substitutes are potentially dangerous because they are high in potassium.

Answer to Question 2

ANS: B
ACE inhibitors, such as captopril, inhibit aldosterone and thus may contribute to the development of hyperkalemia. Beta blockers, such as propranolol, do not affect potassium levels. Loop diuretics, such as furosemide, cause hypokalemia. NSAIDs, such as ibuprofen, do not affect potassium levels.





 

Did you know?

There are 20 feet of blood vessels in each square inch of human skin.

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

The FDA recognizes 118 routes of administration.

For a complete list of videos, visit our video library